OBJECTIVE: The aim of this study was to expand the research on psychiatric complications of end-stage renal disease (ESRD), as well as to examine the prevalence of a broad range of psychopathology in diabetic and non-diabetic hemodialysis (HD) patients. METHODS: One hundred nineteen HD patients were invited to enter the cross-sectional study. To assess quality of life, quality of sleep, mental status and depression and anxiety symptoms, the 36-item Short Form, Pittsburgh Sleep Quality Index (PSQI), Mini-Mental State Examination and Hospital Anxiety and Depression Scale, respectively, were used. RESULTS: The mean age of all patients was 56.9±16.1 years; 54 (45.4%) were female. In the diabetic patients group, 84.8% of the patients had low MCS scores, and 89.2% patients had low PCS scores; 73.9% were poor sleepers; 63.0% had cognitive decline; 62.0% patients were depressive symptoms; and 28.3%had symptoms of anxiety. When comparing the diabetic and non-diabetic patients, the diabetic patients had lower role-emotional, sleep duration, and sleep efficiency scores. CONCLUSIONS: Incorporating a standard assessment and, eventually, treatment of psychopathologic symptoms into the care provided to diabetic and hemodialysis patients might improve quality of life and sleep, depressive symptoms and, reduce mortality risk.
OBJECTIVE: The aim of this study was to expand the research on psychiatric complications of end-stage renal disease (ESRD), as well as to examine the prevalence of a broad range of psychopathology in diabetic and non-diabetic hemodialysis (HD) patients. METHODS: One hundred nineteen HDpatients were invited to enter the cross-sectional study. To assess quality of life, quality of sleep, mental status and depression and anxiety symptoms, the 36-item Short Form, Pittsburgh Sleep Quality Index (PSQI), Mini-Mental State Examination and Hospital Anxiety and Depression Scale, respectively, were used. RESULTS: The mean age of all patients was 56.9±16.1 years; 54 (45.4%) were female. In the diabeticpatients group, 84.8% of the patients had low MCS scores, and 89.2% patients had low PCS scores; 73.9% were poor sleepers; 63.0% had cognitive decline; 62.0% patients were depressive symptoms; and 28.3%had symptoms of anxiety. When comparing the diabetic and non-diabeticpatients, the diabeticpatients had lower role-emotional, sleep duration, and sleep efficiency scores. CONCLUSIONS: Incorporating a standard assessment and, eventually, treatment of psychopathologic symptoms into the care provided to diabetic and hemodialysis patients might improve quality of life and sleep, depressive symptoms and, reduce mortality risk.
Entities:
Keywords:
Anxiety; depression; diabetes mellitus; hemodialysis patients; quality of life; quality of sleep
Authors: Simone Aparecida de Lima Condé; Natália Fernandes; Fabiane Rossi dos Santos; Alfredo Chouab; Márcia Maria Elia Peruzzi da Mota; Marcus Gomes Bastos Journal: J Bras Nefrol Date: 2010 Jul-Sep
Authors: Maurizio Bossola; Claudia Ciciarelli; Enrico Di Stasio; Gian Luigi Conte; Carlo Vulpio; Giovanna Luciani; Luigi Tazza Journal: Gen Hosp Psychiatry Date: 2009-12-05 Impact factor: 3.238
Authors: Sofia Sánchez-Román; Feggy Ostrosky-Solís; Luis E Morales-Buenrostro; M G Nogués-Vizcaíno; Josefina Alberú; Shawn M McClintock Journal: J Int Neuropsychol Soc Date: 2010-11-10 Impact factor: 2.892
Authors: Stacey J Elder; Ronald L Pisoni; Tadao Akizawa; Rachel Fissell; Vittorio E Andreucci; Shunichi Fukuhara; Kiyoshi Kurokawa; Hugh C Rayner; Anna L Furniss; Friedrich K Port; Rajiv Saran Journal: Nephrol Dial Transplant Date: 2007-10-01 Impact factor: 5.992
Authors: Adrian Covic; Anca Seica; Paul Gusbeth-Tatomir; Ovidiu Gavrilovici; David J A Goldsmith Journal: Nephrol Dial Transplant Date: 2004-06-22 Impact factor: 5.992
Authors: Anitra D M Koopman; Joline W Beulens; Tine Dijkstra; Frans Pouwer; Marijke A Bremmer; Annemieke van Straten; Femke Rutters Journal: J Clin Endocrinol Metab Date: 2020-03-01 Impact factor: 5.958